Cargando…
Appraising MicroRNA-155 as a Noninvasive Diagnostic Biomarker for Cancer Detection: A Meta-Analysis
Cancer has been a major public health issue all over the world and cancer patients diagnosed at early stages have a comparatively favorable prognosis. The association between specific dysregulated expressed microRNA-155 (miRNA-155, miR-155) and tumorigenesis has been identified by numerous studies....
Autores principales: | Hou, Yi, Wang, Jing, Wang, Xianwen, Shi, Shaomin, Wang, Wanli, Chen, Zhiying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718262/ https://www.ncbi.nlm.nih.gov/pubmed/26765436 http://dx.doi.org/10.1097/MD.0000000000002450 |
Ejemplares similares
-
Serum CXCL8 and CXCR2 as diagnostic biomarkers for noninvasive screening of cervical cancer
por: Zhang, Nianzhu, et al.
Publicado: (2023) -
Identification of Serum microRNA-25 as a novel biomarker for pancreatic cancer
por: Yu, Yiwen, et al.
Publicado: (2020) -
A Comprehensive Meta-Analysis of MicroRNAs for Predicting Colorectal Cancer
por: Yan, Lin, et al.
Publicado: (2016) -
The value of microRNA-21 as a biomarker for the prognosis of lung cancer: A protocol for systematic review and meta-analysis
por: Zhang, Wei, et al.
Publicado: (2020) -
The prognostic and diagnostic values of MicroRNA-10b in gastric cancer: A comprehensive study based on meta-analysis and TCGA database
por: Mei, Lina, et al.
Publicado: (2020)